etidronate has been researched along with Bright Disease in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, Y | 1 |
| Imakiire, T | 1 |
| Yamada, M | 1 |
| Saigusa, T | 1 |
| Hyodo, T | 1 |
| Kushiyama, T | 1 |
| Higashi, K | 1 |
| Hyodo, N | 1 |
| Yamamoto, K | 1 |
| Suzuki, S | 1 |
| Miura, S | 1 |
| Schlangen, JT | 1 |
| Pauwels, EK | 1 |
1 trial available for etidronate and Bright Disease
| Article | Year |
|---|---|
Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease.
Topics: Adolescent; Adult; Aged; Bone Density Conservation Agents; Bone Diseases, Metabolic; Dose-Response R | 2007 |
1 other study available for etidronate and Bright Disease
| Article | Year |
|---|---|
[The diagnosis of pulmonary calcinosis by scintigraphy (author's transl)].
Topics: Adolescent; Adult; Aged; Calcinosis; Diagnosis, Differential; Etidronic Acid; Female; Glomerulonephr | 1976 |